Literature DB >> 6292180

Down-regulation of the interferon receptor.

A A Branca, C Baglioni.   

Abstract

The binding of 125I-labeled alpha A interferon to human lymphoblastoid Daudi cells decreased when these cells were incubated with unlabeled alpha or beta interferon. This decrease could not be accounted for by the occupancy of interferon receptors with unlabeled interferon and it apparently resulted from the loss or down-regulation of receptors. The binding activity gradually increased when Daudi cells were incubated in fresh medium after a treatment with interferon, but inhibition of protein synthesis with cycloheximide prevented this recovery. Treatment of Daudi cells with this inhibitor resulted in the loss of half the interferon binding activity within 5 h. These findings suggested that the interferon receptors turn over at a basal rate in interferon-free medium and at an increased rate in cells incubated with interferon. The dose-response for the down-regulation was investigated by treating Daudi cells with different concentrations of alpha interferon. Down-regulation was observed in cells treated with relatively low doses of interferon, sufficient to elicit a biological response. The synthesis of the enzyme (2',5')oligo(A) polymerase was induced at the lowest interferon concentrations tested which caused receptor down-regulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292180

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Modulation of epidermal growth factor receptors by human alpha interferon.

Authors:  K C Zoon; Y Karasaki; D L zur Nedden; R Q Hu; H Arnheiter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.

Authors:  O Kloke; R Becher; N Niederle
Journal:  Blut       Date:  1987-11

3.  Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.

Authors:  A Takeda; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

Review 4.  The biology of interferon actions.

Authors:  G Gastl; C Huber
Journal:  Blut       Date:  1988-05

Review 5.  Interferon receptors.

Authors:  A A Branca
Journal:  In Vitro Cell Dev Biol       Date:  1988-03

6.  The gene for the human immune interferon receptor is located on chromosome 6.

Authors:  A Rashidbaigi; J A Langer; V Jung; C Jones; H G Morse; J A Tischfield; J J Trill; H F Kung; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

7.  Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy.

Authors:  A S Lau; G E Hannigan; M H Freedman; B R Williams
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

Review 8.  Interferons and viruses: an evolutionary arms race of molecular interactions.

Authors:  Hans-Heinrich Hoffmann; William M Schneider; Charles M Rice
Journal:  Trends Immunol       Date:  2015-02-20       Impact factor: 16.687

9.  Receptor mediated pathways for interferon action: in vivo implications.

Authors:  K E Mogensen; M T Bandu; F Vignaux; G Uze; P Eid
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

10.  Binding of 125I-labeled recombinant beta interferon (IFN-beta Ser17) to human cells.

Authors:  E C O'Rourke; R J Drummond; A A Creasey
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.